Pasiniazid is a medication belonging to the hydrazide drug class. It is commonly used to treat tuberculosis by hindering the growth of Mycobacterium tuberculosis. The drug is usually administered orally and can be used in combination with other drugs. However, it may cause side effects such as nausea, vomiting, and liver damage.
| Catalog Number | I002591 |
| CAS Number | 2066-89-9 |
| Molecular Formula | C13H14N4O4 |
| Purity | 95% |
| Solubility | 10 mM in DMSO |
| Storage | Room temperature |
| IUPAC Name | 4-amino-2-hydroxybenzoic acid;pyridine-4-carbohydrazide |
| InChI | InChI=1S/C7H7NO3.C6H7N3O/c8-4-1-2-5(7(10)11)6(9)3-4;7-9-6(10)5-1-3-8-4-2-5/h1-3,9H,8H2,(H,10,11);1-4H,7H2,(H,9,10) |
| InChIKey | RKPHTRVPGYGVQD-UHFFFAOYSA-N |
| SMILES | C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN |
| Reference | <p style=/line-height:25px/> |
